Yitzhak Peterburg
2017
In 2017, Yitzhak Peterburg earned a total compensation of $6.8M as Former Interim President and CEO at Teva Pharmaceutical Industries.
Compensation breakdown
| Option Awards | $1,500,009 |
|---|---|
| Salary | $1,534,467 |
| Stock Awards | $2,999,991 |
| Other | $737,071 |
| Total | $6,771,538 |
Peterburg received $3M in stock awards, accounting for 44% of the total pay in 2017.
Peterburg also received $1.5M in option awards, $1.5M in salary and $737.1K in other compensation.
Rankings
In 2017, Yitzhak Peterburg's compensation ranked 1,236th out of 14,666 executives tracked by ExecPay. In other words, Peterburg earned more than 91.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,236 out of 14,666 | 92nd |
Division Manufacturing | 420 out of 5,772 | 93rd |
Major group Chemicals And Allied Products | 111 out of 2,075 | 95th |
Industry group Drugs | 77 out of 1,731 | 96th |
Industry Pharmaceutical Preparations | 61 out of 1,333 | 95th |
Source: SEC filing on April 25, 2018.
Peterburg's colleagues
We found nine more compensation records of executives who worked with Yitzhak Peterburg at Teva Pharmaceutical Industries in 2017.
2017
Kåre Schultz
Teva Pharmaceutical Industries
Chief Executive Officer
2017
Rob Koremans
Teva Pharmaceutical Industries
Chief Executive Officer
2017
Carlo de Notaristefani
Teva Pharmaceutical Industries
Executive Vice President, Global Operations
2017
Michael Hayden
Teva Pharmaceutical Industries
Chief Scientific Officer
2017
Eyal Desheh
Teva Pharmaceutical Industries
Chief Financial Officer
2017
Hafrun Fridriksdottir
Teva Pharmaceutical Industries
Executive Vice President, Global Research and Development
2017
Erez Vigodman
Teva Pharmaceutical Industries
Chief Executive Officer
2017
Mark Sabag
Teva Pharmaceutical Industries
Executive Vice President, Global Human Resources
2017
Michael McClellan
Teva Pharmaceutical Industries